Kissel TH - Search Results

1

Inflammatory responses to pulmonary application of PEI-based siRNA nanocarriers in mice.

Beyerle A, Braun A, Banerjee A, Ercal N, Eickelberg O, Kissel TH, Stoeger T. Beyerle A, et al. Among authors: kissel th. Biomaterials. 2011 Nov;32(33):8694-701. doi: 10.1016/j.biomaterials.2011.07.082. Epub 2011 Sep 8. Biomaterials. 2011. PMID: 21855131

2

In vitro cytotoxic and immunomodulatory profiling of low molecular weight polyethylenimines for pulmonary application.

Beyerle A, Höbel S, Czubayko F, Schulz H, Kissel T, Aigner A, Stoeger T. Beyerle A, et al. Toxicol In Vitro. 2009 Apr;23(3):500-8. doi: 10.1016/j.tiv.2009.01.001. Toxicol In Vitro. 2009. PMID: 19444927

3

Toxicity pathway focused gene expression profiling of PEI-based polymers for pulmonary applications.

Beyerle A, Irmler M, Beckers J, Kissel T, Stoeger T. Beyerle A, et al. Mol Pharm. 2010 Jun 7;7(3):727-37. doi: 10.1021/mp900278x. Mol Pharm. 2010. PMID: 20429563

4

Comparative in vivo study of poly(ethylene imine)/siRNA complexes for pulmonary delivery in mice.

Beyerle A, Braun A, Merkel O, Koch F, Kissel T, Stoeger T. Beyerle A, et al. J Control Release. 2011 Apr 10;151(1):51-6. doi: 10.1016/j.jconrel.2010.12.017. Epub 2011 Jan 9. J Control Release. 2011. PMID: 21223987

5

Poly(ethylene imine) nanocarriers do not induce mutations nor oxidative DNA damage in vitro in MutaMouse FE1 cells.

Beyerle A, Long AS, White PA, Kissel T, Stoeger T. Beyerle A, et al. Mol Pharm. 2011 Jun 6;8(3):976-81. doi: 10.1021/mp1004492. Epub 2011 Apr 7. Mol Pharm. 2011. PMID: 21446747

6

Polymer-related off-target effects in non-viral siRNA delivery.

Merkel OM, Beyerle A, Beckmann BM, Zheng M, Hartmann RK, Stöger T, Kissel TH. Merkel OM, et al. Among authors: kissel th. Biomaterials. 2011 Mar;32(9):2388-98. doi: 10.1016/j.biomaterials.2010.11.081. Epub 2010 Dec 22. Biomaterials. 2011. PMID: 21183213

7

Nonviral siRNA delivery to the lung: investigation of PEG-PEI polyplexes and their in vivo performance.

Merkel OM, Beyerle A, Librizzi D, Pfestroff A, Behr TM, Sproat B, Barth PJ, Kissel T. Merkel OM, et al. Mol Pharm. 2009 Jul-Aug;6(4):1246-60. doi: 10.1021/mp900107v. Mol Pharm. 2009. PMID: 19606864

8

PEGylation affects cytotoxicity and cell-compatibility of poly(ethylene imine) for lung application: structure-function relationships.

Beyerle A, Merkel O, Stoeger T, Kissel T. Beyerle A, et al. Toxicol Appl Pharmacol. 2010 Jan 15;242(2):146-54. doi: 10.1016/j.taap.2009.10.001. Epub 2009 Oct 12. Toxicol Appl Pharmacol. 2010. PMID: 19822165

9

Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection.

Lipka J, Semmler-Behnke M, Sperling RA, Wenk A, Takenaka S, Schleh C, Kissel T, Parak WJ, Kreyling WG. Lipka J, et al. Biomaterials. 2010 Sep;31(25):6574-81. doi: 10.1016/j.biomaterials.2010.05.009. Epub 2010 Jun 9. Biomaterials. 2010. PMID: 20542560

10

Enhancing in vivo circulation and siRNA delivery with biodegradable polyethylenimine-graft-polycaprolactone-block-poly(ethylene glycol) copolymers.

Zheng M, Librizzi D, Kılıç A, Liu Y, Renz H, Merkel OM, Kissel T. Zheng M, et al. Biomaterials. 2012 Sep;33(27):6551-8. doi: 10.1016/j.biomaterials.2012.05.055. Epub 2012 Jun 16. Biomaterials. 2012. PMID: 22710127

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

264 results

Search Page

Filters